3 FTSE 100 Stocks To Buy On St. Leger Day: Barclays PLC, GlaxoSmithKline plc & Vodafone Group plc

Here’s why Barclays PLC (LON: BARC), GlaxoSmithKline plc (LON: GSK) and Vodafone Group plc (LON: VOD) could be worth buying right now.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

city

‘Sell in May and don’t come back until St. Leger Day’ is a well-known stock-market saying. In other words, sell shares in May and buy when the St. Leger Day races commence in early September. The reason for the saying is that summer rallies tend to be infrequent and, in fact, history suggests that a summer pullback is not at all uncommon. Indeed, the FTSE 100 is no higher now than it was in May 2014, so those investors who sold up and went away have not missed out on any gains.

However, it’s now early September and, with the FTSE 100 still failing to push past 7,000 points, this could be a great time to buy the following three stocks.

Barclays

Since the start of May, Barclays (LSE: BARC) has seen its share price fall by 11% as investor sentiment has severely weakened. While this week’s news of a £500 million loss on the sale of part of its Spanish operations may seem like yet more bad news, Barclays continues to make good progress with its disposal programme. Certainly, this will cause short-term pain, but may also set the bank up for improved profitability moving forward.

With shares in the bank trading on a price to earnings (P/E) ratio of just 10.3 and Barclays being forecast to increase its bottom line by an impressive 25% next year, the presently low ebb in sentiment could prove to be an ideal buying opportunity.

GlaxoSmithKline

GlaxoSmithKline (LSE: GSK) is also down 11% since the start of May, with shares in the pharmaceutical major continuing to be hit hard by allegations of bribery. Long-term investors, though, should see this as a buying opportunity as opposed to a reason to panic.

GlaxoSmithKline continues to have a hugely impressive and diversified drugs pipeline which, in the long run, should help the company to considerably grow its bottom line. Furthermore, shares in the company are priced to sell, with GlaxoSmithKline trading on a P/E ratio of just 13 and offering a stunning yield of 5.6%. As with Barclays, weak sentiment could equate to a superb buying opportunity.

Vodafone

It’s a similar story with Vodafone (LSE: VOD): you’d have been better off selling at the start of May, since shares in the company have fallen by 8% since then. However, the future could be much brighter than the past for the European-focused operator, with its strategy of buying undervalued Eurozone assets taking time to come good.

However, should it do so, Vodafone could see its bottom line grow at an impressive rate as it has bought high-quality assets at very attractive prices. In addition, shares in Vodafone currently yield 5.5%, which highlights the company’s income potential at a time when low interest rates look set to be the ‘new normal’.

 

Peter Stephens owns shares of Barclays and GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature black woman at home texting on her cell phone while sitting on the couch
Investing Articles

Could this cheap FTSE 100 stock be the next Rolls-Royce?

Paul Summers casts his eye over a battered-but-high-quality FTSE 100 stock. Is this the next top-tier company to stage a…

Read more »

ISA Individual Savings Account
Investing Articles

Hesitant over a Stocks and Shares ISA? Here’s a way to deal with scary markets

Volatile stock markets are scaring potential investors away from getting started with their first Stocks and Shares ISA in 2026.

Read more »

This way, That way, The other way - pointing in different directions
Market Movers

Standard Life’s announced a £2bn deal but its share price is largely unchanged. Why?

James Beard considers why the Standard Life share price didn’t take off today (15 April) after the group announced it…

Read more »

Happy parents playing with little kids riding in box
Investing Articles

Up 12% in a month, Hollywood Bowl is a UK dividend stock on a roll

This 5%-yielding dividend stock was one of the top performers in the FTSE 250 index today. What sent it flying…

Read more »

Close-up of children holding a planet at the beach
Investing Articles

Young investors are taking the stock market on a rollercoaster ride. Here’s how retirees can buckle up

Mark Hartley reveals the volatile impact that younger investors are having on the stock market and how UK retirees can…

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

£7,500 invested in Aviva shares 5 years ago is now worth…

A lump sum pumped into Aviva shares half a decade ago has grown a lot. Andrew Mackie looks at the…

Read more »

Young female hand showing five fingers.
Investing Articles

Could £20,000 invested in these 5 dividend shares produce £14,760 of passive income over the next 10 years?

James Beard considers the potential of dividend shares to deliver amazing levels of passive income. Here are five that have…

Read more »

Workers at Whiting refinery, US
Investing Articles

At 570p, is it too late to consider buying BP shares?

Since the end of February, when the conflict in the Middle East started, BP shares have soared nearly 20%. But…

Read more »